Entries by Aj Cheline

UC Davis-Enabled Startup Delix Therapeutics Secures $70 Million in Series A Funding

By Neelanjana Gautam UC Davis-enabled neuroscience startup Delix Therapeutics recently closed a $70 million Series A funding round. Co-founded by David E. Olson, associate professor in the Department of Chemistry and the Department of Biochemistry & Molecular Medicine, the preclinical startup is focused on developing safe, non-hallucinogenic, take-home medications for patients suffering from neuropsychiatric illnesses. […]

Team Research Forum: Epigenetics

The UC Davis Office of Research and the UC Davis School of Medicine invite you to join this session with Dr. Hong Ji and Dr. Janine LaSalle for a discussion about the application of epigenetics to study the effects of environmental exposures (e.g. wildfire smoke) and material/perinatal health. View Recording     Long-term epigenetic impact […]

UC Davis School of Medicine tests potential COVID-19 treatments and vaccines

by Nadine Yehya With more than 41.5 million cases and a year and a half after the first confirmed COVID-19 case in the U.S, the search for a safe and effective cure to coronavirus continues. As the pandemic spread around the globe, researchers at  the School of Medicine partnered with drug developers and funding agencies […]

Team Research Forum: COVID-19 Variants

  View Recording Rapid Monitoring for Variants of SARS-CoV-2 by SNP Genotyping and Sequencing Dr. Richard Michelmore Distinguished Professor Director, Genome Center Novozymes Endowed Chair in Genomics A Community Approach to Controlling COVID-19: Healthy Davis Together Brad H. Pollock, M.P.H., Ph.D. Distinguished Professor and Chairman, Arline Miller Rolkin Chair in Public Health Sciences Department of […]

Host Factor Targeted Drug Discovery for SARS-CoV-2 Through an International Collaboration

The Office of Research and School of Medicine are offering a new series of forums to help researchers maximize their impact through team research. Join us online, August 27, 2021, to learn about new advancements in targeted drug discovery for SARS-CoV-2. View Recording Speaker: Dr. Nevan Krogan Professor, Cellular Molecular Pharmacology UCSF School of Medicine […]